Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
SNSE
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct | 2,500 Added 0.05% |
$9,125
$3.65 p/Share
|
Feb 25
2022 |
|
SNSE
|
James Peyer |
BUY
Open market or private purchase
|
Indirect | 2,500 Added 0.05% |
$9,125
$3.65 p/Share
|
Feb 25
2022 |
|
AUGG
|
Donald Richard Taylor
President and CEO |
BUY
Open market or private purchase
|
Direct | 40,000 Added 3.7% |
$34,800
$0.87 p/Share
|
Feb 25
2022 |
|
APEN
|
John J Molesphini
EVP, Operations |
BUY
Grant, award, or other acquisition
|
Direct | 17,227 Added 15.68% |
-
|
Feb 25
2022 |
|
APEN
|
Christopher J. Gostout
Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct | 12,920 Added 12.52% |
-
|
Feb 25
2022 |
|
OPBK
|
Ock Hee Kim
Director |
BUY
Open market or private purchase
|
Direct | 6,800 Added 1.29% |
$88,060
$12.95 p/Share
|
Feb 25
2022 |
|
PLBC
|
Bj North
EVP and Chief Banking Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 2,125 Reduced 12.28% |
$84,001
$39.53 p/Share
|
Feb 25
2022 |
|
PLBC
|
Bj North
EVP and Chief Banking Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 9,600 Added 35.68% |
$84,000
$8.75 p/Share
|
Feb 25
2022 |
|
ISBA
|
Sarah R Opperman
Director |
BUY
Open market or private purchase
|
Direct | 342 Added 1.75% |
$8,738
$25.55 p/Share
|
Feb 25
2022 |
|
ISBA
|
Vicki L Rupp
Director |
BUY
Open market or private purchase
|
Direct | 391 Added 9.1% |
$9,990
$25.55 p/Share
|
Feb 25
2022 |
|
TCFC
|
James F Di Misa
Director |
SELL
Open market or private sale
|
Direct | 1,106 Reduced 10.91% |
$44,373
$40.12 p/Share
|
Feb 25
2022 |
|
FRBK
|
Andrew J Logue
Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 5,624 Reduced 8.65% |
$29,470
$5.24 p/Share
|
Feb 25
2022 |
|
FRBK
|
Andrew J Logue
Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 15,000 Added 18.75% |
$29,250
$1.95 p/Share
|
Feb 25
2022 |
|
DHX
|
Paul Farnsworth
Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 8,611 Reduced 2.16% |
$49,599
$5.76 p/Share
|
Feb 25
2022 |
|
BCOV
|
Scott Kurnit |
BUY
Open market or private purchase
|
Direct | 13,820 Added 9.95% |
$99,919
$7.23 p/Share
|
Feb 25
2022 |
|
BKSY
|
Johan G Broekhuysen
Chief Financial Officer |
BUY
Open market or private purchase
|
Direct | 12,000 Added 2.59% |
$32,400
$2.7 p/Share
|
Feb 25
2022 |
|
BRBS
|
Mensel D Dean |
BUY
Open market or private purchase
|
Indirect | 1,000 Added 1.34% |
$16,390
$16.39 p/Share
|
Feb 25
2022 |
|
ANIK
|
Thomas Finnerty
EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct | 832 Reduced 3.87% |
$26,732
$32.13 p/Share
|
Feb 25
2022 |
|
ANIK
|
Thomas Finnerty
EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct | 2,834 Added 11.64% |
-
|
Feb 25
2022 |
|
AIRS
|
Dennis Dean
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 18,396 Added 3.04% |
-
|
Feb 25
2022 |
|
AIRS
|
Aaron Rollins
Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct | 64,386 Added 0.44% |
-
|
Feb 25
2022 |
|
AIRS
|
Ronald P. Zelhof
COO and President |
BUY
Grant, award, or other acquisition
|
Direct | 21,156 Added 1.78% |
-
|
Feb 25
2022 |
|
RBOT
|
Philip Liang
Director |
SELL
Other acquisition or disposition
|
Indirect | 265,990 Reduced 9.77% |
-
|
Feb 25
2022 |
|
PRTS
|
Lev Peker
Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct | 122 Added 0.01% |
$996
$8.16 p/Share
|
Feb 25
2022 |
|
PRTS
|
David Meniane
Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct | 122 Added 0.01% |
$996
$8.16 p/Share
|
Feb 25
2022 |
|
PRTS
|
Alfredo Gomez
VP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct | 91 Added 0.02% |
$743
$8.16 p/Share
|
Feb 25
2022 |
|
PRTS
|
Houman Akhavan
Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct | 61 Added 0.02% |
$498
$8.16 p/Share
|
Feb 25
2022 |
|
EWTX
|
Jonathan D Root |
SELL
Other acquisition or disposition
|
Indirect | 3,473,543 Reduced 100.0% |
-
|
Feb 25
2022 |
|
RSVR
|
Stephen M. Cook |
BUY
Open market or private purchase
|
Indirect | 6,479 Added 3.29% |
$47,167
$7.28 p/Share
|
Feb 25
2022 |
|
IRMD
|
Roger E. Susi
CEO, PRESIDENT, CHAIRMAN |
SELL
Open market or private sale
|
Indirect | 10,000 Reduced 1.36% |
$470,000
$47.0 p/Share
|
Feb 25
2022 |
|
FMNB
|
Alan Troy Adair
SEVP, CFO |
BUY
Grant, award, or other acquisition
|
Direct | 6,885 Added 30.42% |
-
|
Feb 25
2022 |
|
FMNB
|
Kevin J Helmick
President & CEO |
BUY
Grant, award, or other acquisition
|
Direct | 21,213 Added 14.29% |
-
|
Feb 25
2022 |
|
FMNB
|
Brian E Jackson
Sr VP/CIO |
BUY
Grant, award, or other acquisition
|
Direct | 3,699 Added 12.34% |
-
|
Feb 25
2022 |
|
FMNB
|
Michael G Oberhaus
VP, Chief Risk Officer |
BUY
Grant, award, or other acquisition
|
Direct | 3,494 Added 12.79% |
-
|
Feb 25
2022 |
|
FMNB
|
Timothy F Shaffer
SEVP, Chief Banking Officer |
BUY
Grant, award, or other acquisition
|
Direct | 4,841 Added 11.23% |
-
|
Feb 25
2022 |
|
FMNB
|
Mark J Wenick
SEVP/ Chief Wealth Mgr |
BUY
Grant, award, or other acquisition
|
Direct | 5,657 Added 21.05% |
-
|
Feb 25
2022 |
|
FMNB
|
Amber B Wallace
Sr VP/Chief Retail/Marketing |
BUY
Grant, award, or other acquisition
|
Direct | 4,303 Added 10.09% |
-
|
Feb 25
2022 |
|
HCKT
|
Maria De Los Angeles Bofill
Director |
SELL
Sale (or disposition) back to the issuer
|
Direct | 3,962 Reduced 45.51% |
$81,221
$20.5 p/Share
|
Feb 25
2022 |
|
HCKT
|
Alan T G Wix
Director |
SELL
Sale (or disposition) back to the issuer
|
Direct | 11,962 Reduced 42.34% |
$245,221
$20.5 p/Share
|
Feb 25
2022 |
|
HCKT
|
Robert A Rivero
Director |
SELL
Sale (or disposition) back to the issuer
|
Direct | 4,962 Reduced 57.0% |
$101,721
$20.5 p/Share
|
Feb 25
2022 |
|
HCKT
|
John R Harris
Director |
SELL
Sale (or disposition) back to the issuer
|
Direct | 5,151 Reduced 9.54% |
$105,596
$20.5 p/Share
|
Feb 25
2022 |
|
HCKT
|
Richard N Hamlin
Director |
SELL
Sale (or disposition) back to the issuer
|
Direct | 4,962 Reduced 9.2% |
$101,721
$20.5 p/Share
|
Feb 25
2022 |
|
MX
|
Woung Moo Lee |
SELL
Open market or private sale
|
Direct | 13,000 Reduced 11.93% |
$237,250
$18.25 p/Share
|
Feb 25
2022 |
|
COWN
|
Lorence H. Kim |
BUY
Open market or private purchase
|
Direct | 30,000 Added 50.0% |
$900,900
$30.03 p/Share
|
Feb 25
2022 |
|
GOOD
|
Robert G Cutlip
President |
BUY
Open market or private purchase
|
Direct | 1,000 Added 1.66% |
$20,920
$20.92 p/Share
|
Feb 25
2022 |
|
BHE
|
Jeff Benck
President and CEO |
BUY
Grant, award, or other acquisition
|
Direct | 74,124 Added 20.7% |
-
|
Feb 25
2022 |
|
BHE
|
Rhonda R Turner
SVP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct | 9,607 Added 20.37% |
-
|
Feb 25
2022 |
|
BHE
|
Stephen J Beaver
SVP, General Counsel and CLO |
BUY
Grant, award, or other acquisition
|
Direct | 13,420 Added 21.35% |
-
|
Feb 25
2022 |
|
BHE
|
Jan M Janick
SVP, Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct | 9,652 Added 13.71% |
-
|
Feb 25
2022 |
|
BHE
|
Michael D. Buseman
EVP, Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct | 16,077 Added 20.51% |
-
|
Feb 25
2022 |